Pharma Mar, S.A. (LON: 0RC6)
London
· Delayed Price · Currency is GBP · Price in EUR
73.87
0.00 (0.00%)
Jul 21, 2022, 6:20 PM BST
Pharma Mar Revenue
Pharma Mar had revenue of 45.66M EUR in the quarter ending September 30, 2024, with 21.90% growth. This brings the company's revenue in the last twelve months to 167.00M, down -0.86% year-over-year. In the year 2023, Pharma Mar had annual revenue of 158.15M, down -19.45%.
Revenue (ttm)
167.00M EUR
Revenue Growth
-0.86%
P/S Ratio
n/a
Revenue / Employee
328.10K EUR
Employees
509
Market Cap
1.17B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 158.15M | -38.19M | -19.45% |
Dec 31, 2022 | 196.34M | -33.49M | -14.57% |
Dec 31, 2021 | 229.83M | -40.13M | -14.87% |
Dec 31, 2020 | 269.96M | 184.14M | 214.57% |
Dec 31, 2019 | 85.82M | -22.95M | -21.10% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |